Delivery Order SPE2DR25D3103-SPE2DR26F9F25
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $4,438.25 and a firm fixed price structure. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by November 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract value of $37,834.09. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $7,034.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,808.87 and an ultimate completion date of October 16, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance of this delivery will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $28,970.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a component of the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $7,756.44. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside program and is scheduled for ultimate completion by August 7, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,968.48 for Dapagliflozin 10 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a specific pharmaceutical fulfillment under DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 tablets, valued at $1,540.36. This is a firm fixed-price delivery order with an ultimate completion date of November 17, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,472.58 with firm fixed pricing and an ultimate completion date of July 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F25Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, valued at $1,198.39. This non-competitive, firm fixed-price delivery order was awarded without a set-aside designation and is scheduled for completion by November 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant role in the federal medical procurement supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through multiple therapeutic product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/13/25 |